HealtheMed greatly improves the lives of the sickest and poorest Medicaid patients


Raised to Date: Raised: $113,528

Aggregate Commitments $


Start Date


Close Date


Min. Goal


Max. Goal


Min. Investment


Security Type


Funding Type




Valuation Cap


Discount Rate


Rolling Commitments $
Reporting Date


Days Remaining
% of Min. Goal


% of Max. Goal


Likelihood of Max
Avg. Daily Raise


# of Investors


Log in or create a free account today to gain access to KingsCrowd analytics.

Mendota Heights, Minnesota


Healthcare & Pharmaceuticals

Tech Sector


Distribution Model




Capital Intensity


Business Type


HealtheMed, with a $3 million valuation cap, is raising crowdfunding on Wefunder. It is a telemedicine platform that allows sick and poor patients to see their doctors online. The platform specifically focuses on special needs patients who live confined in their homes and suffer from chronic diseases like quadriplegia and muscular dystrophy. Thomas Spencer and Robert Arnold founded HealtheMed in 2018. The proceeds of the current crowdfunding round, with a minimum goal of $50,000 and a maximum goal of $600,000, will be used to launch and commence operations, including payroll, sales, and marketing. HealtheMed has a contract with the Minnesota Medicaid program targeting 77,000 potential subscribers. The company also has an exclusive contract with MMCAP Infuse for marketing HealtheMed to its 12,000 institutional customers.
Summary Profit and Loss Statement
Most Recent Year Prior Year












Net Income



Summary Balance Sheet
Most Recent Year Prior Year




Accounts Receivable



Total Assets



Short-Term Debt



Long-Term Debt



Total Liabilities



Financials as of: 08/17/2020
Log in or create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)


$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual


$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Staff Picks (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual


$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.


Analyst Report


HealtheMed has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected into the top 10%-20% of our due diligence funnel. If you have questions regarding our deal diligence and selection methodology, please reach out to

Analysis written by Katy Dolan.


Despite the United States’ status as one of the wealthiest countries in the world, the U.S. healthcare system lags far behind other wealthy countries. Americans have a lower life expectancy than citizens in countries like Switzerland and Japan. And they are far more likely to experience health conditions like diabetes, heart disease, lung disease, and disability. In fact, the U.S. healthcare system costs more money to produce worse outcomes than almost any other healthcare system in the world. 

Healthcare access and affordability is particularly difficult for low-income or otherwise vulnerable Americans. Those individuals are predominantly covered by Medicare or Medicaid, the federal government’s nationwide public health care programs. While Medicare is focused on elderly Americans, Medicaid provides health coverage for low-income adults. 

Medicaid expansion — additional funding to provide health care to more low-income individuals — was a central feature of President Obama’s Affordable Care Act (ACA). Although it remains a controversial political issue, studies have shown that states that expanded Medicaid access saw better health outcomes. Medicaid has long been associated with better health and provides care of similar quality to private insurance plans

However, Medicaid is less effective for enrollees that suffer from disability or chronic illness. That population represents roughly a third of Medicaid participants nationwide. Yet the cost of their more specialized care totals 70 percent of total Medicaid spending. Healthcare for disabled Medicaid participants is uniquely complex, and patients struggle to locate doctors and maintain treatment schedules. Over 10 million Americans qualify for Medicaid coverage based on disability, and the U.S. healthcare system has a long way to go in ensuring their access to quality care.


HealtheMed is a telemedicine company partnering with state Medicaid providers to install telemedicine systems (hardware plus software) in the homes of disabled or chronically-ill Medicaid patients. HealtheMed patients receive a smart TV and other Bluetooth-enabled medical devices that connect to a care network with the patient’s doctor. These devices then allow doctors to perform day-to-day treatment and preventative care within the patient’s home. 

This convenient access to care increases the likelihood that patients stick to treatment plans and avoid needless health complications. In HealtheMed’s pilot studies, patients’ medication adherence increased from 43% to 92%. At-home care is timely for these patients, as they are the most at risk of serious complications or death if infected by COVID-19. Doctors in the HealtheMed system can monitor patients for potential symptoms of COVID-19 from afar, without the patients risking a trip to the clinic. 

While many telemedicine and healthcare startups partner with existing healthcare giants like insurance companies to deliver care through a middleman, HealtheMed partners directly with government Medicaid providers. These direct relationships make HealtheMed a cost effective solution for healthcare providers. They also net the company larger margins. 

HealtheMed’s first paying contract is with Minnesota’s Medicaid program. There are 77,000 potential subscribers in the Minnesota system. HealtheMed will be paid $3,600 per year for each subscriber. HealtheMed markets to social workers to encourage them to enroll their clients in the HealtheMed program. 

HealtheMed has not formally launched, and the company has not generated revenue since its founding in 2018. Last year, the company operated at a net loss of $13,000.


HealtheMed is led by president and CEO Thomas Spencer. He is a longtime healthcare professional with previous experience leading a healthcare company and advising several other companies as a consultant. Spencer is joined by Robert Arnold, HealtheMed’s COO. Arnold has worked for several healthcare companies over the last 10 years, primarily in sales and marketing. He previously founded two SaaS companies with reported 5x and 3x returns for investors. HealtheMed’s founding team also includes Ronald Mandelbaum as the Chief Revenue Officer. He has worked in sales and business development for a number of firms in HR, materials, and conservation over the last 20 years.

Growth Plan

HealtheMed is raising a seed round, split between accredited investors and crowdfunders, before beginning to fulfil its contract with the state of Minnesota.

After launching that contract, HealtheMed will expand to other states. The company has an exclusive contract with MMCAP Infuse — a national government healthcare group purchasing organization — and will receive marketing rights to the organization’s 12,000 institutional members across 50 states.

Why We Like it

  • Unique direct-to-government business model: HealtheMed is somewhat unique among telemedicine companies in that it contracts directly with state Medicaid offices. This model removes the complexity and margin loss from middleman deals with insurance providers and other large healthcare players. It is true that reliance on government contracts is somewhat risky given how difficult it typically is to close those sales cycles. However, HealtheMed has already secured a contract with one state and has a nationwide partnership that will provide insider access to additional stakeholders. These are both encouraging factors in the company’s favor.


  • Telemedicine solution at a critical medical moment: The COVID-19 pandemic has rapidly accelerated the adoption of telemedicine. Many patients are not leaving quarantine to visit clinics and hospitals for anything less than life-threatening circumstances. HealtheMed patients — low-income patients with disabilities or chronic illnesses — are particularly vulnerable to COVID and other contagious viruses like the flu. The HealtheMed telemedicine solution is ideally suited for the newfound urgency of their home-based care. 


HealtheMed has secured a unique relationship with a state Medicaid provider to pilot its telemedicine solution for low-income and disabled patients. This system is particularly well-suited for the COVID moment. It also has the potential to win widespread adoption as more and more states address both the immediate and long-term health needs of Medicaid patients. 

That being said, HealtheMed is a very early-stage company with little to prove in the way of operational success. The company has demonstrated some traction through their Minnesota Medicaid contract and partnership with a nationwide group purchasing organization. But it remains to be seen whether the company will actually be able to facilitate large-scale care with its somewhat complex hardware and software solution. The company is also vulnerable to competition from more technologically-advanced companies — whether startups or incumbents — that might easily overtake HealtheMed due to its lack of technical leadership on the founding team. 

If HealtheMed can succeed in its launch contract and continues to expand to win market share in other states, it has solid options for exit. Telemedicine is a booming industry with rabid interest from venture capitalists and other funders, particularly since COVID hit. This early-stage capitalization leads to major exits, whether by acquisition or IPO. Teladoc — a leader in the space that itself went public — acquired a competitor earlier this year for $600 million. Amwell, another virtual care provider, may be the next valuable telemedicine IPO.

While HealtheMed is a very young company, it has already secured a potentially lucrative contract with the state of Minnesota. It also has the potential to line up additional partnerships quickly after proving operational capacity later this year. The company’s business model is unique among telemedicine startups and is all the more attractive during a global pandemic. Therefore, HealtheMed is a Deal to Watch. 

Other Deals

Cheers on StartEngine

Alcohol consumption is one of the oldest human practices on record. A study released in…

EnGen Bio on Wefunder

COVID-19 has brought the world’s attention to vaccine development. In April 2021, a record 4

Audubon Bioscience on MicroVentures

In 2020 alone, companies produced, tested, and began to produce a vaccine for a completely new virus on…

Create your first portfolio

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add HealtheMed on Wefunder
Follow company
Follow HealtheMed on Wefunder
Want to learn more about HealtheMed?
Join the Pre-IPO Market’s #1 Ratings & Analytics Service FREE for 7 days.
Yes! I want to start my free trial.
Already a member? Log in here.